Trials / Recruiting
RecruitingNCT06677437
Endovascular Preparation for Kidney Tranplantation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This national study is a feasibility study. It wants to validate all stages of the endovascular preparation of the iliac axis up to the kidney transplant for patients in whom the installation of a tailor-made endoprosthesis was necessary beforehand. These patients are currently at a therapeutic impasse. This strategy of renal transplantation on an iliac artery endoprosthesis could ultimately give them access to the transplant with an improvement in quality of life and survival, for lower costs of care for the hospital and safety. less social than treatment by hemodialysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This is an observational and retrospective study | It concerns all patients with chronic renal failure awaiting a kidney transplant, and presenting a contraindication to the transplant due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses. They can only receive the kidney transplant after arterial preparation. These patients will be included and will benefit from endovascular preparation for the kidney transplant using a tailor-made arterial stent. Imaging examinations and follow-up clinical data will be analyzed. Reinterventions and causes of death will be analyzed. An information sheet will be given to patients; if the patient refuses the use of their data, it will not be collected. Data collection will be carried out by ARCs or PIs of the centers from medical records. The data will be pseudo-anonymized, entered into a REDCAP database shared between each center. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-01-01
- Completion
- 2028-01-01
- First posted
- 2024-11-06
- Last updated
- 2024-11-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06677437. Inclusion in this directory is not an endorsement.